LH
Labcorp Holdings Inc. · Healthcare
CEO, Covance Drug Development Paul R Kirchgraber sold $2.0M of Labcorp Holdings Inc.
Sold$2,004,675
$250.58Price
8,000Shares
−47%Stake
What LH did after the filing
- The stock from Thu, Feb 23 open, $208.93
- −4.5%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Apr 6 close.
Traded Tue, Feb 21. Filed Thu, Feb 23, 4:54 AM ET, before the open. Returns use the Feb 23 open and the Apr 6 close. Not investment advice.